Asia-Pacific Pharmaceutical: Controlling shareholders propose repurchasing shares of 10-20 million yuan.

Asia Pacific Pharmaceutical announced that on July 21st, the company's actual controller, chairman, and general manager Qiu Zhongxun proposed that the company repurchase shares. The total amount of repurchase funds shall not be less than 10 million yuan and not more than 20 million yuan, sourced from own funds and/or self-raised funds, with an implementation period of up to 12 months from the date of approval by the board of directors. The repurchased shares will be used for employee stock ownership plans or equity incentives, and any unused portion after three years will be cancelled in accordance with the law. This matter is subject to approval procedures and there is uncertainty.